Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-03 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-04 John Clifford, Ph.D.
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.
Balu, Mihaela

University Of California-Irvine
United States

Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma 4R01CA259019-04 PAR-20-155 (R01 Clinical Trial Optional) Guillermo Marquez, Ph.D.
Banerjee, Imon

Mayo Clinic Arizona
United States

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer 5R01CA289249-02 Nicholas Hodges, Ph.D.
Bao, Ting

Dana-Farber Cancer Inst
United States

Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial 5R01CA251470-06 Goli Samimi, Ph.D., M.P.H.
Bartolini, Francesca

Columbia University Health Sciences
United States

Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN 5R01CA279401-02 Rachel Altshuler, Ph.D.
Bast, Robert C

University Of Tx Md Anderson Can Ctr
United States

MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm 5U01CA200462-08 Christos Patriotis, Ph.D., M.Sc.